Cargando…
Economic implications of FDA platelet bacterial guidance compliance options: Comparison of single‐step strategies
BACKGROUND: Bloodborne pathogens pose a major safety risk in transfusion medicine. To mitigate the risk of bacterial contamination in platelet units, FDA issues updated guidance materials on various bacterial risk control strategies (BRCS). This analysis presents results of a budget impact model upd...
Autores principales: | Prioli, Katherine M., Abersone, Ilze, Kopko, Patricia M., Herman, Jay H., Custer, Brian, Pizzi, Laura T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303536/ https://www.ncbi.nlm.nih.gov/pubmed/34997763 http://dx.doi.org/10.1111/trf.16778 |
Ejemplares similares
-
Performance profile of an updated safety measure rapid assay for bacteria in platelets
por: Vallejo, Remo P., et al.
Publicado: (2020) -
Evaluation of an improved rapid bacterial assay with untreated and pathogen‐reduced platelets: Detection of Acinetobacter strains
por: LaVerda, David, et al.
Publicado: (2021) -
Acquired platelet storage container leaks and contamination with environmental bacteria: A preventable cause of bacterial sepsis
por: Gammon, Richard R., et al.
Publicado: (2021) -
A WHO tool for risk‐based decision making on blood safety interventions
por: Janssen, Mart P., et al.
Publicado: (2020) -
Determination of Babesia microti seroprevalence in blood donor populations using an investigational enzyme immunoassay
por: Levin, Andrew E, et al.
Publicado: (2014)